Trump's Subtle Tariff Strategy: A New Approach to Trade Policy
ByAinvest
Saturday, Jul 19, 2025 5:04 am ET1min read
AAPL--
Trump has threatened a 200% tariff on pharmaceuticals after a one-year grace period, with a low initial tariff to allow companies to shift production back to the US. Semiconductor tariffs are also on a similar timeline, with Trump suggesting they will be “less complicated” to enforce [1]. These actions come as part of Trump's ongoing trade policy, which he has described as the “most beautiful word in the dictionary” [2].
If enacted, the pharmaceutical tariffs could significantly impact major drugmakers like Eli Lilly, Merck, and Pfizer, who rely heavily on overseas production. Meanwhile, chip tariffs are expected to affect tech giants like Apple and Samsung, potentially driving up prices for consumer electronics [1].
Trump's tariff strategy has been criticized for not focusing on national security, as required by law. However, he maintains that the volume of drug imports poses a threat to the US. His administration has also threatened tariffs on a range of other products, including steel, aluminum, and washing machines, under Section 232 [1].
The threat of these tariffs comes as Trump has issued tariff letters to several trading partners, outlining import duties unilaterally. However, he insists that negotiations are still on the table. Earlier this week, Trump announced a revised deal with Indonesia, cutting its proposed tariff rate from 32% to 19% in exchange for multibillion-dollar US purchases, including 50 Boeing aircraft [1].
References:
[1] https://timesofindia.indiatimes.com/business/international-business/us-pharma-threats-donald-trump-warns-of-drug-tariffs-by-month-end-semiconductor-leviesmayfollow/articleshow/122548866.cms
[2] https://www.tradecomplianceresourcehub.com/2025/07/14/trump-2-0-tariff-tracker/
BA--
LLY--
MRK--
PFE--
President Trump's tariff strategy involves two sets of tariffs, authorized by the International Emergency Economic Powers Act (IEEPA) and Section 232 of a 1962 trade law. The IEEPA tariffs are announced in country-by-country letters, while Section 232 tariffs are imposed on various products, such as pharmaceuticals. Trump has used Section 232 extensively, with nine investigations ongoing, and has imposed tariffs on a range of products, including steel, aluminum, and washing machines. Critics argue that Trump's tariffs are not focused on national security, as required by law.
President Donald Trump has announced potential tariffs on imported pharmaceuticals and semiconductors, signaling an escalation in his broader “reciprocal tariff” strategy. The tariffs, authorized by the International Emergency Economic Powers Act (IEEPA) and Section 232 of the Trade Expansion Act of 1962, aim to bolster domestic production and address national security concerns [1].Trump has threatened a 200% tariff on pharmaceuticals after a one-year grace period, with a low initial tariff to allow companies to shift production back to the US. Semiconductor tariffs are also on a similar timeline, with Trump suggesting they will be “less complicated” to enforce [1]. These actions come as part of Trump's ongoing trade policy, which he has described as the “most beautiful word in the dictionary” [2].
If enacted, the pharmaceutical tariffs could significantly impact major drugmakers like Eli Lilly, Merck, and Pfizer, who rely heavily on overseas production. Meanwhile, chip tariffs are expected to affect tech giants like Apple and Samsung, potentially driving up prices for consumer electronics [1].
Trump's tariff strategy has been criticized for not focusing on national security, as required by law. However, he maintains that the volume of drug imports poses a threat to the US. His administration has also threatened tariffs on a range of other products, including steel, aluminum, and washing machines, under Section 232 [1].
The threat of these tariffs comes as Trump has issued tariff letters to several trading partners, outlining import duties unilaterally. However, he insists that negotiations are still on the table. Earlier this week, Trump announced a revised deal with Indonesia, cutting its proposed tariff rate from 32% to 19% in exchange for multibillion-dollar US purchases, including 50 Boeing aircraft [1].
References:
[1] https://timesofindia.indiatimes.com/business/international-business/us-pharma-threats-donald-trump-warns-of-drug-tariffs-by-month-end-semiconductor-leviesmayfollow/articleshow/122548866.cms
[2] https://www.tradecomplianceresourcehub.com/2025/07/14/trump-2-0-tariff-tracker/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet